Skip to main content

Identification of higenamine in Radix Aconiti Lateralis Preparata as a beta2-adrenergic receptor agonist

Buy Article:

$43.00 plus tax (Refund Policy)


Aim: To screen beta2-adrenergic receptor (2-AR) agonists from Radix Aconiti Lateralis Preparata (RALP) as potential drug leads for asthma using a sensitive cell-based agonist assay. Methods: The 2-AR gene was stably expressed by Chinese hamster ovary (CHO) cells also stably expressing a cyclic adenosine monophosphate (AMP) response element-linked enhanced green fluorescent protein reporter gene. The cells were used to screen agonists from high-performance liquid chromatographic fractions of an extract of RALP. The fraction with the highest activity was selected for further compound isolation and the study of the structure-activity relationship. Its active compound was further identified by chromatography and mass spectrometry. Results: Bioactivity-directed fraction-ation of the crude extract of RALP led to the isolation and characterization of the effective compound, namely hignamine. It could dose-dependently relax the isolated guinea pig trachea strip precontraction with acetylcholine with EC50 value of (2.60±0.36) × 10−5 mol/L. Further in vivo studies also displayed that hignamine could protect experimental asthma model induced by histamine in guinea pigs to prolong the latent periods of asthma. Conclusion: Hignamine, as a 2-AR agonist existing in the extract of RALP, is the key compound contributing to the successful relief of the bronchoconstriction.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Radix Aconiti Lateralis Preparata (RALP); asthma; beta2-adrenergic receptor (2-AR) agonists; herbal medicines; higenamine

Document Type: Research Article

Affiliations: 1: College of Life Sciences, Nankai University, Tianjin 300071, China 2: College of Pharmaceutical Sciences, Nankai University, Tianjin 300071, China

Publication date: 01 October 2008

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more